DPYSL3 and gastric cancer: Patients with upregulated DPYSL3 had a significantly higher prevalence of lymph node metastasis, overall distant metastasis and peritoneal dissemination, indicating that DPYSL3 is a metastasis facilitator of GC, and high expression of DPYSL3 may predict the metastatic behavior associated with an invasive GC phenotype.